Cannabis
Drug Plants Vs Manufactured Products: What’s Better?
When it comes to plant drugs, you often have the option of the plant, or manufactured products. Which is better? Read on…
Plant drugs
Not every drug is a plant. Though some like LSD and MDMA are based on plants or are synthesized using plants (ergot fungus and sassafras, respectively), some popular drugs, are nothing but a plant. Think of weed. We call it by this word because it’s literally a weed that grows by roadsides in many places. It doesn’t require any preparation beyond heating it; and plenty is gained without heat at all. Magic mushrooms are another great example of a basic plant drug that can be pulled from the ground and ingested, with no further preparation.
Beyond this, we have a range of drugs that started as natural, but were then processed into something stronger. Like heroin. Heroin is morphine processed with ascetic acid. Or cocaine, a processed form of coca leaves that involves nitric acid. In these cases there’s a certain amount of processing that goes on, but its done around the basis of the original plant. However, due to the processing; the results are a much more intense product. Cocaine is even processed further to make crack, a more intense version of cocaine.
Plant drugs have been used for thousands of years, long past recorded history. Some of what we know comes from fossilized findings, and carbon dated remnants. In terms of recorded history, from medical books to scripture; plants factor in as far as recordings go back. Different locations of the world worked with what they each had available. And they often came to the exact same understandings of a plant, in differing periods and locations; for which there would have been no communication or ways to share ideas.
Plants were (and are) widely used for spiritual purposes by many indigenous tribes the world over; as well as for medical treatments, and recreational use. Sometimes they are used so much, and so entrenched in culture; that modern governments allow them. Peyote is a great example. It’s used so widely by native cultures in the US, the federal government finally legalized the plant for spiritual use; a law that applies to anyone who wants to use the plant for this purpose, even beyond native tribes.
Synthetic drugs
The other side in plants vs manufactured products, is the manufactured products. These fall into two categories in my mind: products that are made from a plant, but produced in a different form; or completely synthesized, lab-made drugs. In either case, these products don’t grow directly out of the ground.
When it comes to products made from the plant, without creating a new drug; one of the best examples is vape products for cannabis and tobacco. And by this I specifically mean oil vapes, since dry herb vapes don’t require any level of production for the weed used. Oil vapes are vapes that use oil cartridges, and these cartridges contain compounds from the plants, that are leached into the oil. Instead of dealing with the plant, the user just deals with an oil cartridge and a battery.
Edible products are also included here. A brownie is not directly weed, and a gummy is not directly a mushroom. The drugs must be processed to some degree to create an edible form. This is something the average person can do in their kitchen with the right setup; but something for which there is a large and growing sales market, as well. Whereas you can choose what to put in when cooking at home; store-bought products include whatever ingredients the given company chose for their recipe.
When it comes to synthesized lab-made drugs, some examples are drugs like LSD, MDMA, antidepressants, synthetic opioids, Tylenol, and methamphetamine. There is no original form of any of these, so the only way they exist, is as lab-made products. Whether they’re synthesized using a plant is not important; as the drugs themselves are too different from the plants that they’re made from, to be associated with them in terms of effects.
Plants vs manufactured products – when manufactured is better
Some drugs only exist as one or the other. There is no natural form of methamphetamine, but there is also no lab-made version of salvia. Others exist in both realms. You can eat amanita mushrooms, or buy the gummy version; and same with cannabis. Both of these plants, and their accompanying industries, are great examples of the difference between plants and manufactured products.
Which is better? This is a matter of opinion. When it comes to weed, some manufactured products, like vapes, provide a more intense high than the plant itself; because they’re a more concentrated version. This is a useful concept for medicating; when often a very strong version of something is needed to get a medical effect. The weed industry provides both options, plants and manufactured products; and either can be decent in terms of effects, with manufactured products often offering a more intense experience.
Amanita mushrooms are another plant drug that has a good reason for manufacturing. These mushrooms come with a main compound that can make a person sick; though not enough to die. This compound, ibotenic acid, can be processed out through the decarboxylation method of boiling. This can be done by the individual who wants to use them; or by manufacturers who produce gummies or other edible products. In the latter case, all the user must do, is eat the product.
Manufactured products also come with the upside of dosing. We don’t all want or need the same amount, but its hard to know how much of the active compounds (or dangerous compounds) we’re taking in, when consuming plant material. Manufactured products generally have measured levels of compounds, creating a consistent experience; and making it easier for those who are less familiar with something, to get it right. This idea of consistency promotes the API market for pharmaceuticals.
Plants vs manufactured products – when plants are better
There are some issues, however, with manufactured products. Just like they can sometimes be more potent than their plant counterparts, sometimes it’s the opposite. Amanita mushrooms are once again a an applicable example. They’re newer to American culture, and don’t have a history of use as a plant. But they’re also hallucinogenic mushrooms (though different from psilocybin, as they work mainly off the compound muscimol). Producers seem generally afraid to create products with full-blown effects, which creates a market of products that don’t do much, even though the mushrooms themselves, do.
In terms of products being too strong, this is also an issue. A newer rise in emergency room visits is connected with very high THC products, which have become the norm. Whereas plants don’t generally have more than 20% THC (although this amount is incredibly inflated from earlier decades), manufactured products boast numbers like 90% THC. This is no longer in the standard realm of today; and its not shocking that more people get sick. Luckily, THC overdoses are not deadly, just uncomfortable.
Another issue is companies adding toxic substances. Not only does weed not need a lot of pesticides or other chemicals, it wasn’t an industry associated with them as a black market. Yet now with mass legal production, we’re suddenly dealing with sprayed weed, and overuse of agricultural chemicals. What once was a clean black market, is now a grossly dirty legal market; yet its the legal market that always brags about testing. Even though those tests back up just how dirty legal production is.
And then think about vapes. Weed might be sprayed with chemicals, but it doesn’t have to be. A vape cart doesn’t exist without the addition of some chemicals. Some are used that don’t have to be, like flavoring or colorants. But other things are necessary since its not a standard state for weed to be in, and it has to be preserved for transport. As such, things like stabilizers and preservatives (vitamin e-acetate) come into play. And this is beyond whatever other tinkering a manufacturer might do.
The same can be said for gummies, and other edibles. The US food market is not a pretty place, because regulation allows for tons of dangerous chemicals in food production. Sure, its possible to make a clean cannabis or mushroom edible, just like its possible to grow organic vegetables, or produce clean meat. However, just because something can happen, doesn’t mean it will. Edibles are food products; and liable to have a list of chemical ingredients, that only people with high level science degrees can pronounce.
Final thoughts
The reality is that for some drugs, both a plant option and a manufactured option, exist. It comes down to a buyer’s personal decision as to what is better. If you want the most basic, unadulterated form; the plant is best. But if you need a stronger product, want the convenience of vapes or edibles, need specific dosing, or have more trust in manufactured products; then this is probably the better option. Either way, if its well made/grown, you should definitely catch a buzz.
Hey all! Cool that you’re with us at Cannadelics.com; a news source in the independent realm, reporting on the most interesting stories in the growing cannabis and hallucinogen worlds. Hang out with us regularly to catch the updates; and get signed up to the Cannadelics Weekly Newsletter; so you’re always up on what’s going down.
Related
There is a buzz about sore throats today. While they are most common in colder months, spring allergies bring the pain also. This is often due to postnasal drip, which is when mucus from the nose and sinuses drains down the back of the throat, causing irritation and a scratchy feeling. Overuse of the voice, like talking loudly or singing for long periods, can tire out and strain the muscles in your throat, causing them to feel sore. The good news is cannabis can help a sore throat.
RELATED: How Hemp Helps You Sleep
For those seeking natural alternatives to manage cold symptoms, cannabis is emerging as a promising option for throat irritation. Increasing research at medical center specifically targeting sore throats shows early insights. The data suggests cannabinoids and terpenes could offer symptom relief through their unique properties.
Cannabis contains compounds like THC and CBD, which studies indicate possess anti-inflammatory properties that may reduce throat swelling and irritation. Terpenes such as eucalyptol—found in some strains—are traditionally associated with decongestant effects, potentially easing respiratory discomfort. These components work synergistically to calm inflamed tissues, though their direct impact on sore throats requires further clinical validation.
Smoking cannabis while ill remains controversial due to potential throat irritation from heat and smoke. Instead, experts recommend gentler options:
-
Edibles/lozenges: THC or CBD-infused products bypass inhalation, delivering localized relief without aggravating the throat.
-
Cannabis tea: Warm beverages with cannabis extracts may soothe scratchy throats while providing hydration.
-
Tinctures: Sublingual CBD oils allow precise dosing and avoid respiratory irritation.
Beyond direct throat relief, cannabis may improve overall wellness during illness. THC’s appetite-stimulating properties can combat reduced hunger, while its relaxing effects might promote restorative sleep. CBD’s muscle-relaxing qualities could help alleviate the body aches often accompanying colds.
RELATED: How To Stop Coughing So Hard From Marijuana Smoke
While preliminary findings are encouraging, users should consult healthcare providers before combining cannabis with conventional cold medications due to potential interactions. Starting with low-dose CBD products may offer benefits without psychoactive effects. As legalization expands, more targeted research is expected to clarify cannabis’s role in respiratory health.
Innovative cannabis formulations—from throat-calming lozenges to anti-inflammatory teas—are redefining how we approach minor ailments. For those navigating cold season, these plant-based solutions present a compelling fusion of traditional herbal wisdom and modern cannabinoid science
Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.
The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster. With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes. Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.
RELATED: Music Is A Turn On Like Sex And Marijuana
The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.
During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.
The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.
The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.
RELATED: The Science Behind Why Music Sounds So Much Better When You’re High
While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.
States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.
The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.
RELATED: Mike Johnson And Marijuana
“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”
Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds. Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.
States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.
In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.
RELATED: Marijuana Use And Guy’s Member
Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.
The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.
This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.
Former New York Knick Iman Shumpert debuts ‘TSA Approved’ legal cannabis brand
How New York pot pioneers made it to legal dispensary shelves
Scientists Now Think That One Compound in the Cannabis Plant Can Replace All Opiates
Vladimir Bautista is leading Happy Munkey’s legacy-to-legal takeover
Cannabis Can Help A Sore Throat
Cannabis and the Authoritarian State
As cannabis consumer tastes evolve, industry must look beyond potency
Article: Early 2025 Empire State Psychedelic Policy Roundup
White House Finally Comments On Marijuana Industry
Stop Using Bat Poop to Fertilize Your Weed Plants Immediately, Here is Why…
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
-
Cannabis News2 years agoDistressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years agoUnited States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years agoWhat you Need to Know
-
drug testing1 year agoDrug Testing for Marijuana – The Joint Blog
-
Education2 years agoNCIA Write About Their Equity Scholarship Program
-
Cannabis2 years agoIt has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years agoCannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years agoA new April 20 cannabis contest includes a $40,000 purse